Aberrant expression of miRNA and mRNAs in lesioned tissues of graves' disease

Cellular Physiology and Biochemistry

Volumn 35, Issue 5, 2015, Pages 1934-1942

  Qin, Qiu ^a   Wang, Xuan ^a   Yan, Ni ^a   Song, Rong Hua ^a   Cai, Tian Tian ^a   Zhang, Wen ^a   Guan, Li Juan ^a   Muhali, Fatuma Said ^a   Zhang, Jin An ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Graves' disease (GD); MicroRNA; MRNA

Indexed keywords

A KINASE ANCHOR PROTEIN 12; ECTODYSPLASIN A; GLYCINE AMIDINOTRANSFERASE; MESSENGER RNA; MICRORNA; MICRORNA 101; MICRORNA 183; MICRORNA 197; MICRORNA 22; MICRORNA 660; MIXED LINEAGE LEUKEMIA TRANSLOCATED TO 4; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN MULTITYPE 2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GRAVES DISEASE; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MOLECULAR DOCKING; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTOMICS; ADOLESCENT; CASE CONTROL STUDY; DNA MICROARRAY; GENE REGULATORY NETWORK; GENETICS; METABOLISM; PATHOLOGY; THYROID GLAND; UPREGULATION; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; GENE REGULATORY NETWORKS; GRAVES DISEASE; HUMANS; MALE; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID GLAND; UP-REGULATION; YOUNG ADULT;

EID: 84927930174     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000374002     Document Type: Article

References (40)

1. Prabhakar BS, Bahn RS, Smith TJ: Current perspective on the pathogenesis of Graves' disease and opthalmopathy. Endocr Rev 2003;24:802-835.
2. Teng W, Shan Z, Teng X, Guan H, Li Y, Teng D, Jin Y, Yu X, Fan C, Chong W, Yang F, Dai H, Yu Y, Li J, Chen Y, Zhao D, Shi X, Hu F, Mao J, Gu X, Yang R, Tong Y, Wang W, Gao T, Li C: Effect of iodine intake on thyroid diseases in China. N Engl J Med 2006;354:2783-2793.
3. Selmi C: Hot topic in autoimmune diseases: perspectives from the 2013 Asian Congress of Autoimmunity. Autoimmun Rev 2014;13:781-787.
4. Carthew RW, Sontheimer EJ: Origins and mechanisms of miRNA and siRNAs. Cell 2009;136:642-655.
5. Lindsay MA: MicroRNA and the immune response. Trends Immunol 2008;29:343-351.
6. Pauley KM, Cha S, Chan EK: MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 2009;32:189-194.
7. Dai R, Ahmed S: MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res 2011;157:163-179.
8. Nakamachi Y, Kawano S, Takenokuchi M, Nishimura K, Sakai Y, Chin T, Saura R, Kurosaka M, Kumagai S: MicroRNA-124a is key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 2009;60:1294-1304.
9. Wang H, Peng W, Ouyang X, Li W, Dai Y: Circulating microRNA as candidate biomarkers in patients with systemic lupus erythematosus. Transl Res 2012;160:198-206.
10. Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, Huang X, Zhou H, de Vries N, Tak PP, Chen S, Shen N: MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009;60:1065-1075.
11. Xia P, Fang X, Zhang ZH, Huang Q, Yan KX, Han L, Zheng ZZ: Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions. Immunol Lett 2012;148:151-162.
12. Du C, Liu C, Kang J, Zhao G, Ye Z, Huang S, Li Z, Wu Z, Pei G: MicroRNA miR-326 regulates Th-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 2009;10:1252-1259.
13. Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, Bayless TM, Brant SR, Chakravarti S, Kwon JH: MicroRNA are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008;135:1624-1635.
14. Maierhaba M, Zhang JA, Yu ZY, Wang Y, Xiao WX, Quan Y, Dong B:. Association of the thyroglobulin gene polymorphism with autoimmune thyroid disease in Chinese population. Endocrine 2008;33:294-299.
15. Song RH, Qin Q, Yan N, Muhali FS, Meng S, He ST, Zhang JA: Variants in IRAK1-MECP2 region confer susceptibility to autoimmune thyroid diseases. Mol Cell Endocrinol 2015;399:244-249.
16. Qin Q, Liu P, Liu L, Wang R, Yan N, Yang J, Wang X, Pandey M, Zhang JA: The increased but non-predominant expression of Th17-and Th1-specific cytokines in Hsahimoto's thyroiditis but not in Graves' disease. Braz J Med Biol Res 2012;45:1202-1208.
17. Song RH, Yu ZY, Qin Q, Wang X, Muhali FS, Shi LF, Jiang WJ, Xiao L, Li DF, Zhang JA: Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditis. Int J Clin Exp Pathol 2014;7:4024-4031.
18. Zhu C, Ma J, Liu Y, Tong J, Tian J, Chen J, Tang X, Xu H, Lu L, Wang S: Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 2012;97:943-950.
19. Wittmann J, Jäck HM: Serum microRNA as powerful cancer biomarkers. Biochim Biophys Acta 2010;1806:200-207.
20. Spoerl D, Duroux-Richard I, Louis-Plence P, Jorgensen C: The role of miR-155 in regulatory T cells and rheumatoid arthritis. Clin Immunol 2013;148:56-65.
21. Fenoglio C, Cantoni C, De Riz M, Ridolfi E, Cortini F, Serpente M, Villa C, Comi C, Monaco F, Mellesi L, Valelli S, Bresolin N, Galimberti D, Scarpini E: Expression and genetic analysis of miRNA involved in CD4+ cell activation in patients with multiple sclerosis. Neurosci Lett 2011;504:9-12.
22. Dai Y, Huang YS, Tang M, Lv TY, Hu CX, Tan YH, Xu ZM, Yin YB: Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 2007;16:939-946.
23. Jernås M, Malmeström C, Axelsson M, Nookaew I, Wadenvik H, Lycke J, Olsson B: MicroRNA regulate immune pathways in T-cells in multiple sclerosis(MS). BMC Immunol 2013;14:32.
24. Ninomiya M, Kondo Y, Funayama R, Nagashima T, Kogure T, Kakazu E, Kimura O, Ueno Y, Nakayama K, Shimoseqawa T: Distinct microRNA expression profile in primary billiary cirrhosis and evaluation of miR 505-3p and miR 197-3p as novel biomarkers. PLoS One 2013;8:e66086.
25. Dai R, Zhang Y, Khan D, Heid B, Caudell D, Crasta O, Ahmed SA: Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS One 2010;:e14302.
26. Rigby RJ, Vinuesa CG: SiLEncing SLE: the power and promise of small noncoding RNAs. Curr Opin Rheumatol 2008;20:526-531.
27. Nicoloso MS, Kipps TJ, Croce CM, Calin GA: MicroRNA in the pathogeny of chronic lymphocytic leukaemia. Br J Haematol 2007;139:709-716.
28. Calin GA, Croce CM: Genomics of chronic lymphocytic leukemia microRNA as new players with clinical significance. Semin Oncol 2006;33:167-173.
29. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C, Bartucci M, Muto G, Peschle C, De Maria R: The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 2008;14:1271-1277.
30. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CM: Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007;179:5082-5089.
31. Liu R, Ma X, Xu L, Wang D, Jiang X, Zhu W, Cui B, Ning G, Lin D, Wang S: Differential microRNA expression in peripheral blood mononuclear cells from Graves' disease patients. J Clin Endocrinol Metab 2012;97:E968-972.
32. Iborra M, Bernuzzi F, Correale C, Vetrano S, Fiorino G, Beltrán B, Marabita F, Locati M, Spinelli A, Nos P, Invernizzi P, Danese S: Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease. Clin Exp Immunol 2013;173:250-258.
33. Wu F, Zhang S, Dassopoulos T, Harris ML, Bayless TM, Meltzer SJ, Brant SR, Kwon JH: Identification of microRNA associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis 2010;16:1729-1738.
34. Stanczyk J, Pedrioli DM.L, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE, Detmar M, Gay S, Kyburz D: Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 2008;58:1001-1009.
35. Fulci V, Scappucci G, Sebastiani GD, Giannitti C, Franceschini D, Meloni F, Colombo T, Citarella F, Barnaba V, Minisola G, Galeazzi M, Macino G: miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum Immunol 2010;71:206-211.
36. Dai Y, Sui W, Lan H, Yan Q, Huang H, Huang Y: Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 2009;29:749-754.
37. Bostjancic E, Glavac D: Importance of microRNA in skin morphogenesis and diseases. Acta Dermatovenerol Alp Panonica Adriat 2008;17:95-102.
38. Sonkoly E, Wei T, Janson PC, Sääf A, Lundeberg L, Tengvall-Linder M, Norstedt G, Alenius H, Homey B, Scheynius A, Ståhle M, Pivarcsi A: MicroRNA: novel regulators involved in the pathogenesis of psoriasis? PLoS One 2007;2: e610.
39. Bernecker C, Halim F, Lenz L, Haase M, Nguyen T, Ehlers M, Vordenbaeumen S, Schott M: MicroRNA expressions in CD4+ and CD8+ T-cell subsets in autoimmune thyroid diseases. Exp Clin Endocrinol Diabetes 2014;122:107-112.
40. Yamada H, Itoh M, Hiratsuka I, Hashimoto S: Circulating microRNAs in autoimmune thyroid diseases. Clin Endocrinol(oxf) 2014;81:276-281.